MA
Meyer Andrew Hollman
OFFICER
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Meyer Andrew Hollman. Director active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 7 filings have been published. Activity tracked since 27 September 2024. The latest transaction was disclosed on 1 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
3,333 shares@ US$4.212.9% of flowCommon StockSEC:0001415889-25-011874:0
3,334 shares@ US$4.212.8% of flowCommon StockSEC:0001415889-25-011243:0
3,334 shares@ US$4.213.1% of flowCommon StockSEC:0001415889-25-007104:0
3,334 shares@ US$4.213.2% of flowCommon StockSEC:0001415889-25-003165:0
18,000 shares0Common StockSEC:0001415889-25-000554:0
9,880 shares@ US$20.2444.6% of flowCommon StockSEC:0001415889-24-029989:0
50,000 shares@ US$4.2143.5% of flowCommon StockSEC:0001415889-24-024078:0